Find Daprodustat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 960539-70-2, Gsk1278863, Gsk-1278863, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl)glycine, Gsk 1278863, Jvr38zm64b
Molecular Formula
C19H27N3O6
Molecular Weight
393.4  g/mol
InChI Key
RUEYEZADQJCKGV-UHFFFAOYSA-N
FDA UNII
JVR38ZM64B

Daprodustat
Daprodustat has been used in trials studying the other, treatment, and basic science of Anaemia, Wound Healing, Tendon Injuries, Surgical Procedures, and Vascular Disease, Peripheral.
1 2D Structure

Daprodustat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid
2.1.2 InChI
InChI=1S/C19H27N3O6/c23-14(24)11-20-16(25)15-17(26)21(12-7-3-1-4-8-12)19(28)22(18(15)27)13-9-5-2-6-10-13/h12-13,15H,1-11H2,(H,20,25)(H,23,24)
2.1.3 InChI Key
RUEYEZADQJCKGV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O
2.2 Other Identifiers
2.2.1 UNII
JVR38ZM64B
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(1,3-dicyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamido)acetic Acid

2. Gsk1278863

2.3.2 Depositor-Supplied Synonyms

1. 960539-70-2

2. Gsk1278863

3. Gsk-1278863

4. N-((1,3-dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl)glycine

5. Gsk 1278863

6. Jvr38zm64b

7. 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinan-5-yl)formamido]acetic Acid

8. Glycine, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl)-

9. Duvroq

10. (1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carbonyl)glycine

11. 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic Acid

12. Daprodustat [usan:inn]

13. Unii-jvr38zm64b

14. Duvroq (tn)

15. Daprodustat [inn]

16. Daprodustat [jan]

17. Daprodustat [usan]

18. Daprodustat [who-dd]

19. Daprodustat; Gsk1278863

20. Daprodustat (jan/usan/inn)

21. Gtpl8455

22. Daprodustat (gsk1278863)

23. Chembl3544988

24. Schembl21725048

25. Dtxsid501337360

26. Amy27907

27. Bcp16766

28. Ex-a1121

29. Mfcd29924726

30. S8171

31. Akos027439964

32. Zinc231226004

33. Ccg-268574

34. Cs-5453

35. Db11682

36. Sb19761

37. Ac-30915

38. Bg166670

39. Hy-17608

40. Db-096637

41. J3.560.573h

42. D10874

43. A902761

44. Q27076986

45. Daprodustat;(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carbonyl)glycine

2.4 Create Date
2015-03-18
3 Chemical and Physical Properties
Molecular Weight 393.4 g/mol
Molecular Formula C19H27N3O6
XLogP32.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass393.18998559 g/mol
Monoisotopic Mass393.18998559 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count28
Formal Charge0
Complexity627
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of anaemia due to chronic disorders


5 Pharmacology and Biochemistry
5.1 ATC Code

B - Blood and blood forming organs

B03 - Antianemic preparations

B03X - Other antianemic preparations

B03XA - Other antianemic preparations

B03XA07 - Daprodustat


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712514600,"product":"\\\"WE HEREBY DECLARE TO CLAIM REWARDS UNDER RODTEP\\\", DAPRODUSTAT","address":"2 FLR.PRESTIGE PLAZA","city":"AKOTA BARODA","supplier":"AMI LIFESCIENCES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"","customer":"EGYPT","customerCountry":"EGYPT","quantity":"0.13","actualQuantity":"0.13","unit":"KGS","unitRateFc":"39555.1","totalValueFC":"5104.8","currency":"USD","unitRateINR":3279116.1538461535,"date":"08-Apr-2024","totalValueINR":"426285.1","totalValueInUsd":"5104.8","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"8987518","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"2 FLR.PRESTIGE PLAZA, AKOTA BARODA","customerAddress":""}]
08-Apr-2024
08-Apr-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty